Partager cet article

Uma DAO para doenças: como a Vibe Bio planeja reestruturar o financiamento da biotecnologia

O fundador da Vibe Bio T estava entusiasmado em criar uma DAO, mas descentralizar a pesquisa de medicamentos poderia resolver um problema espinhoso e trágico.

Mise à jour 11 mai 2023, 6:10 p.m. Publié 15 juil. 2022, 5:11 p.m. Traduit par IA
Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)
Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)